Key result
Ultrasound-assisted catheter-directed thrombolysis achieves clinical and hemodynamic success in ~83% of tricuspid valve thrombosis.
Why the study?
Does ultrasound-assisted catheter-directed thrombolysis (USCDT) improve symptoms, leaflet mobility, and tricuspid regurgitation severity in patients with acute tricuspid mechanical valve thrombosis?
Case Report (n=6)
Does ultrasound-assisted catheter-directed thrombolysis (USCDT) improve symptoms, leaflet mobility, and tricuspid regurgitation severity in patients with acute tricuspid mechanical valve thrombosis?
Ultrasound-assisted catheter-directed thrombolysis demonstrated clinical and hemodynamic improvement in 5 of 6 patients with acute tricuspid mechanical valve thrombosis without complications, offering a potential nonsurgical alternative in an area currently unaddressed by guidelines.
Answers are grounded in this paper and cite their sources.
USCDT may offer a nonsurgical option for tricuspid MVT; hypothesis-generating and requires prospective trials before practice change.
BACKGROUND: Mechanical tricuspid valves are remarkably susceptible to acute mechanical valve thrombosis (MVT). Current guidelines suggest reoperation or systemic thrombolysis for left-sided MVT. These treatments carry substantial operative and bleeding risks, limiting their application. A better nonsurgical treatment for MVT is needed. CASE SUMMARY: Six patients with suspected acute tricuspid MVT were treated with ultrasound-assisted catheter-directed thrombolysis (USCDT). Improvement in symptoms, leaflet mobility, and tricuspid regurgitation severity occurred in 5 of 6 cases with no observed complications. WHY BEYOND THE GUIDELINES?: Tricuspid MVT is not addressed in current guidelines because of a paucity of available data. DISCUSSION: USCDT represents a novel treatment alternative for tricuspid MVT. Direct contact between the USCDT catheter and the mechanical valve may enhance alteplase activity and thrombus dispersion. TAKE-HOME MESSAGE: USCDT may represent an alternative to contemporary treatments for tricuspid MVT and warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Stock et al. (2026) conducted a case report in Suspected acute tricuspid mechanical valve thrombosis (n=6). Ultrasound-assisted catheter-directed thrombolysis (USCDT) with alteplase was evaluated on Improvement in symptoms, leaflet mobility, and tricuspid regurgitation severity. Ultrasound-assisted catheter-directed thrombolysis improved symptoms, leaflet mobility, and tricuspid regurgitation severity in 5 of 6 patients with acute tricuspid MVT without complications.
Synapse has enriched 10 related papers. Consider them for comparative context: